SRx Health Solutions Inc.
SRXHAMEXHealthcare● Active
$0.12
+$0.00(+3.31%)
Market Cap$4248086
P/E Ratio—
52W High$0.78
52W Low$0.079
SRx Health Solutions Inc. (SRXH) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
SRXH · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 14, 2026EPS Actual
-$0.02
Est. -$0.26 · +92.3%
Revenue
$0.00B
Est. $0.00B · -12.2%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 14, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue🔥 5-Quarter EPS Beat Streak
SRXH reports quarterly as a AMEX-listed Drug Manufacturers - General company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 12, 2026 | — | — | — | — | — | — |
| ▲ Q2 FY2026 | May 14, 2026 | -$0.26 | -$0.02 | +92.3% | $0.00B | $0.00B | -12.2% |
| — Q1 FY2026 | Feb 13, 2026 | — | -$0.17 | — | $0.00B | — | — |
| — Q4 FY2025 | Nov 10, 2025 | — | -$0.40 | — | $-0.03B | — | — |
| — Q3 FY2025 | Sep 30, 2025 | — | -$0.74 | — | $0.01B | — | — |
| — Q2 FY2025 | May 15, 2025 | — | -$0.37 | — | $0.01B | — | — |
| ▲ Q1 FY2025 | Mar 27, 2025 | -$4.84 | -$0.50 | +89.7% | $0.00B | $0.01B | -61.4% |
| ▲ Q4 FY2024 | Nov 14, 2024 | -$4.84 | -$0.50 | +89.7% | $0.01B | $0.01B | -44.2% |
Q3 FY2026
Aug 12, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 14, 2026Beat
EPS Actual
-$0.02
EPS Est.
-$0.26
EPS Surpr.
+92.3%
Revenue
$0.00B
Q1 FY2026
Feb 13, 2026
EPS Actual
-$0.17
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2025
Nov 10, 2025
EPS Actual
-$0.40
EPS Est.
—
EPS Surpr.
—
Revenue
$-0.03B
Q3 FY2025
Sep 30, 2025
EPS Actual
-$0.74
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q2 FY2025
May 15, 2025
EPS Actual
-$0.37
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q1 FY2025
Mar 27, 2025Beat
EPS Actual
-$0.50
EPS Est.
-$4.84
EPS Surpr.
+89.7%
Revenue
$0.00B
Q4 FY2024
Nov 14, 2024Beat
EPS Actual
-$0.50
EPS Est.
-$4.84
EPS Surpr.
+89.7%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2026 | $-0.36 | $-0.36 | $-0.36 | 1 |
| Q2 FY2025 | $-6.59 | $-6.59 | $-6.59 | 1 |
| Q1 FY2025 | $-3.15 | $-3.15 | $-3.15 | 1 |
| Q4 FY2024 | $-3.16 | $-3.16 | $-3.16 | 1 |
| Q3 FY2024 | $-2.99 | $-2.99 | $-2.99 | 1 |
| Q2 FY2024 | $-6.02 | $-6.02 | $-6.02 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 14, 2026 | +92.3% | $0.15 | $0.14 | -8.24% |
| — Q1 FY2026 | Feb 13, 2026 | — | $0.15 | $0.15 | -3.63% |
| — Q4 FY2025 | Nov 10, 2025 | — | $0.23 | $0.21 | -7.54% |
| — Q3 FY2025 | Sep 30, 2025 | — | $0.34 | $0.32 | -6.21% |
| — Q2 FY2025 | May 15, 2025 | — | $0.80 | $0.57 | -28.84% |
| ▲ Q1 FY2025 | Mar 27, 2025 | +89.7% | No price data | $2.09 | — |
| ▲ Q4 FY2024 | Nov 14, 2024 | +89.7% | No price data | $2.09 | — |
| ▲ Q4 FY2024 | Nov 12, 2024 | +66.8% | No price data | $2.09 | — |
Q2 FY2026-8.24%
Report Date
May 14, 2026
EPS Beat/Miss
+92.3%
Price Before
$0.15
Price After
$0.14
Q1 FY2026-3.63%
Report Date
Feb 13, 2026
EPS Beat/Miss
—
Price Before
$0.15
Price After
$0.15
Q4 FY2025-7.54%
Report Date
Nov 10, 2025
EPS Beat/Miss
—
Price Before
$0.23
Price After
$0.21
Q3 FY2025-6.21%
Report Date
Sep 30, 2025
EPS Beat/Miss
—
Price Before
$0.34
Price After
$0.32
Q2 FY2025-28.84%
Report Date
May 15, 2025
EPS Beat/Miss
—
Price Before
$0.80
Price After
$0.57
Q1 FY2025—
Report Date
Mar 27, 2025
EPS Beat/Miss
+89.7%
Price Before
—
Price After
$2.09
Q4 FY2024—
Report Date
Nov 14, 2024
EPS Beat/Miss
+89.7%
Price Before
—
Price After
$2.09
Q4 FY2024—
Report Date
Nov 12, 2024
EPS Beat/Miss
+66.8%
Price Before
—
Price After
$2.09
Avg Beat Reaction-8.24%
Beat Rate4 / 8 quarters
Largest Move-28.84% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: SRXH ends December
SRx Health Solutions Inc. (SRXH) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $-0.02 — beating the analyst consensus of $-0.26 by +92.3%. SRXH has beaten EPS estimates for 5 consecutive quarters. The next SRXH earnings date is expected around September 1, 2026.
Each quarter, investors track SRXH earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. SRXH revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
SRXH's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
SRXH earnings · 5 questionsSRx Health Solutions Inc.'s next earnings report is expected around September 1, 2026. SRXH typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; SRXH historically reports after market close (AMC).
SRXH earnings datewhen is SRXH earningsSRXH next earnings datewhen does SRXH report earningsSRXH earnings calendar
▸ Source: FMP · SRx Health Solutions Inc. SEC filings · US GAAP · SRx Health Solutions Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026